evrysdi
roche registration gmbh - risdiplam - vöðvaáfall, mænu - Önnur lyf við sjúkdómum í stoðkerfi - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 500 mg
alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 500 mg
ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 250 mg
alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 250 mg
felden hlaup 0,5 %
pfizer aps - piroxicamum inn - hlaup - 0,5 %
peratsin húðuð tafla 2 mg
orion corporation - perphenazinum inn - húðuð tafla - 2 mg
coxient filmuhúðuð tafla 30 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 30 mg
strefen honung & citron (strefen körsbär & mint) munnholsúði, lausn 16,2 mg/ml
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnholsúði, lausn - 16,2 mg/ml
coxient filmuhúðuð tafla 60 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 60 mg